Table of Contents
1.1 List of Tables 12
1.2 List of Figures 20
2 Introduction 21
2.1 Alzheimer Diagnostic Tests Overview 21
3 Products under Development 22
3.1 Alzheimer Diagnostic Tests – Pipeline Products by Stage of Development 22
3.2 Alzheimer Diagnostic Tests – Pipeline Products by Territory 23
3.3 Alzheimer Diagnostic Tests – Pipeline Products by Regulatory Path 24
3.4 Alzheimer Diagnostic Tests – Pipeline Products by Estimated Approval Date 25
3.5 Alzheimer Diagnostic Tests – Ongoing Clinical Trials 26
4 Alzheimer Diagnostic Tests – Pipeline Products under Development by Companies 27
4.1 Alzheimer Diagnostic Tests Companies – Pipeline Products by Stage of Development 27
4.2 Alzheimer Diagnostic Tests – Pipeline Products by Stage of Development 32
5 Alzheimer Diagnostic Tests Companies and Product Overview 37
6 Alzheimer Diagnostic Tests – Recent Developments 191
7 Appendix 419
Table 1: Alzheimer Diagnostic Tests - Pipeline Products by Stage of Development 22
Table 2: Alzheimer Diagnostic Tests - Pipeline Products by Territory 23
Table 3: Alzheimer Diagnostic Tests - Pipeline Products by Regulatory Path 24
Table 4: Alzheimer Diagnostic Tests - Pipeline Products by Estimated Approval Date 25
Table 5: Alzheimer Diagnostic Tests - Ongoing Clinical Trials 26
Table 6: Alzheimer Diagnostic Tests Companies - Pipeline Products by Stage of Development 27
Table 7: Alzheimer Diagnostic Tests - Pipeline Products by Stage of Development 32
Table 8: AC Immune SA Pipeline Products & Ongoing Clinical Trials Overview 37
Table 9: Abeta-Based Diagnostic Test - Alzheimer´s Disease - Product Status 37
Table 10: Abeta-Based Diagnostic Test - Alzheimer´s Disease - Product Description 38
Table 11: pTau-Based Diagnostic Test - Alzheimer´s Disease - Product Status 38
Table 12: pTau-Based Diagnostic Test - Alzheimer´s Disease - Product Description 38
Table 13: Acobiom Pipeline Products & Ongoing Clinical Trials Overview 39
Table 14: Companion Diagnostic Test - Alzheimer's Disease - Product Status 39
Table 15: Companion Diagnostic Test - Alzheimer's Disease - Product Description 39
Table 16: Diagnostic/Prognostic Assay - Alzheimer's Disease - Product Status 40
Table 17: Diagnostic/Prognostic Assay - Alzheimer's Disease - Product Description 40
Table 18: Acumen Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 41
Table 19: Ultra-high Sensitivity Companion Diagnostic Assay - Product Status 41
Table 20: Ultra-high Sensitivity Companion Diagnostic Assay - Product Description 41
Table 21: Adlyfe Inc Pipeline Products & Ongoing Clinical Trials Overview 42
Table 22: Diagnostic Assay - Alzheimer’s Disease - Product Status 42
Table 23: Diagnostic Assay - Alzheimer’s Disease - Product Description 42
Table 24: Admit Therapeutics SL Pipeline Products & Ongoing Clinical Trials Overview 43
Table 25: Diagnostic Test - Alzheimer's Disease - Product Status 43
Table 26: Diagnostic Test - Alzheimer's Disease - Product Description 43
Table 27: ADx NeuroSciences NV Pipeline Products & Ongoing Clinical Trials Overview 44
Table 28: ADDL'S Biomarker Test - Product Status 44
Table 29: ADDL'S Biomarker Test - Product Description 45
Table 30: Biomarker Assay - Amyloid Ratio High Sensitivity - Product Status 45
Table 31: Biomarker Assay - Amyloid Ratio High Sensitivity - Product Description 45
Table 32: Biomarker Assay - P-Tau Isoforms - Product Status 46
Table 33: Biomarker Assay - P-Tau Isoforms - Product Description 46
Table 34: Biomarker Assay - Tau Isoforms - Product Status 46
Table 35: Biomarker Assay - Tau Isoforms - Product Description 46
Table 36: Blood Based Amyloid Beta Biomarker Test - Product Status 47
Table 37: Blood Based Amyloid Beta Biomarker Test - Product Description 47
Table 38: GLOB. P3N Aß Biomarker Test - Product Status 47
Table 39: GLOB. P3N Aß Biomarker Test - Product Description 48
Table 40: O-TAU Biomarker Test - Product Status 48
Table 41: O-TAU Biomarker Test - Product Description 48
Table 42: SNAP 25 Biomarker Test - Product Status 49
Table 43: SNAP 25 Biomarker Test - Product Description 49
Table 44: Synuclein Oligo Biomarker Test - Product Status 49
Table 45: Synuclein Oligo Biomarker Test - Product Description 50
Table 46: Aelan Cell Technologies Pipeline Products & Ongoing Clinical Trials Overview 51
Table 47: Diagnostic Blood Test - Alzheimer's Disease - Product Status 51
Table 48: Diagnostic Blood Test - Alzheimer's Disease - Product Description 51
Table 49: Agent Biotech Pipeline Products & Ongoing Clinical Trials Overview 52
Table 50: Diagnostic Test - Alzheimer's Disease - Product Status 52
Table 51: Diagnostic Test - Alzheimer's Disease - Product Description 52
Table 52: Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview 53
Table 53: Mitochondrial Preprotein Based Test - Alzheimer’s Disease - Product Status 53
Table 54: Mitochondrial Preprotein Based Test - Alzheimer’s Disease - Product Description 53
Table 55: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 54
Table 56: Diagnostic Assay - Alzheimer’s Disease - Product Status 54
Table 57: Diagnostic Assay - Alzheimer’s Disease - Product Description 54
Table 58: Alzhyme Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 55
Table 59: Diagnostic Test - Alzheimer’s Disease - Product Status 55
Table 60: Diagnostic Test - Alzheimer’s Disease - Product Description 55
List of Figures
Figure 1: Alzheimer Diagnostic Tests - Pipeline Products by Stage of Development 22
Figure 2: Alzheimer Diagnostic Tests - Pipeline Products by Territory 23
Figure 3: Alzheimer Diagnostic Tests - Pipeline Products by Regulatory Path 24
Figure 4: Alzheimer Diagnostic Tests - Pipeline Products by Estimated Approval Date 25
Figure 5: Alzheimer Diagnostic Tests - Ongoing Clinical Trials 26
【免責事項】
https://www.marketreport.jp/reports-disclaimer